Morgan Stanley Maintains Overweight on Olaplex Hldgs, Lowers Price Target to $17.5
Morgan Stanley analyst Dara Mohsenian maintains Olaplex Hldgs (NASDAQ:OLPX) with a Overweight and lowers the price target from $19 to $17.5.
7 Analysts Have This to Say About Olaplex Hldgs
Olaplex Hldgs (NASDAQ:OLPX) has observed the following analyst ratings within the last quarter:
Piper Sandler Maintains Overweight on Olaplex Hldgs, Lowers Price Target to $21
Piper Sandler analyst Korinne Wolfmeyer maintains Olaplex Hldgs (NASDAQ:OLPX) with a Overweight and lowers the price target from $24 to $21.
Olaplex Hldgs Q2 EPS $0.14 Beats $0.13 Estimate, Sales $210.90M Beat $201.26M Estimate
Olaplex Hldgs (NASDAQ:OLPX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.13 by 7.69 percent. The company reported quarterly sales of $210.90 million which beat the
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Olaplex Shares Move Lower On Volume Following Short Report From The Bear Cave Titled ‘Problems at Olaplex Holdings (OLPX)’
https://thebearcave.substack.com/p/problems-at-olaplex-holdings-olpx
Barclays Downgrades Olaplex Hldgs to Equal-Weight, Lowers Price Target to $16
Barclays analyst Lauren Lieberman downgrades Olaplex Hldgs (NASDAQ:OLPX) from Overweight to Equal-Weight and lowers the price target from $17 to $16.
JP Morgan Maintains Overweight on Olaplex Hldgs, Lowers Price Target to $21
JP Morgan analyst Andrea Teixeira maintains Olaplex Hldgs (NASDAQ:OLPX) with a Overweight and lowers the price target from $23 to $21.
What 6 Analyst Ratings Have To Say About Olaplex Hldgs
Within the last quarter, Olaplex Hldgs (NASDAQ:OLPX) has observed the following analyst ratings:
Looking Into Olaplex Hldgs’s Return On Invested Capital
According to Benzinga Pro data Olaplex Hldgs (NASDAQ:OLPX) posted a 10.6% decrease in earnings from Q4. Sales, however, increased by 11.83% over the previous quarter to $186.20 million.